Pembrolizumab for HER2+ gastric cancer
Crossref DOI link: https://doi.org/10.1038/s41571-021-00594-x
Published Online: 2021-12-22
Published Print: 2022-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Killock, David
Text and Data Mining valid from 2021-12-22
Version of Record valid from 2021-12-22
Article History
First Online: 22 December 2021